Copyright
©The Author(s) 2015.
World J Gastrointest Oncol. May 15, 2015; 7(5): 30-46
Published online May 15, 2015. doi: 10.4251/wjgo.v7.i5.30
Published online May 15, 2015. doi: 10.4251/wjgo.v7.i5.30
Table 1 Inherited mutations in DNA repair genes that increase the risk of gastrointestinal cancer
DNA repair gene(s) | Repair pathway(s) affected | Cancers with increased risk |
BLM | HRR[1] | Leukemia, lymphoma, colon, breast, skin, lung, auditory canal, tongue, esophagus, stomach, tonsil, larynx, uterus[2] |
WRN | HRR, NHEJ, long patch BER[3] | Soft tissue sarcoma, colorectal, skin, thyroid, pancreatic[4] |
Fanconi's anemia genes FANCA, B, C, D1, D2, E, F, G, I, J, L, M, N | HRR and TLS[5] | Leukemia, liver tumors, solid tumors in many areas including esophagus, stomach and colon[6] |
MSH2, MSH6, MLH1, PMS2 | MMR[7] | Colorectal, endometrial[7] |
MUTYH | BER of A mispaired with 8-OHdG[8] | Colon[8] |
P53 | HRR, BER, NER, NHEJ, MMR[9] | Sarcoma, breast, osteo-sarcoma, brain, adreno-cortical carcinomas[10] and colon and pancreas[11] |
Table 2 Endogenous DNA damages/cell/day for humans
Table 3 Epigenetic deficiency of DNA repair genes in gastrointestinal cancers and field defects
Cancer | Gene | Frequency in cancer | Frequency in adjacentfield defect |
Colorectal[17] | MGMT | 46% | 34% |
Colorectal[19] | MGMT | 47% | 11% |
Colorectal[60] | MGMT with MSI | 70% | 60% |
Colorectal[19] | MSH2 | 13% | 5% |
Colorectal[61] | MBD4 | Frequent | Frequent |
Colorectal[62] | ERCC1 | 100% | 40% |
Colorectal[62] | PMS2 | 88% | 50% |
Colorectal[62] | XPF | 55% | 40% |
Colorectal[63] | WRN | 29% | 13% |
Stomach[64] | MGMT | 88% | 78% |
Stomach[65] | MLH1 | 73% | 20% |
Esophagus[66] | MLH1 | 77%-100% | 23%-79% |
Table 4 CpG island hyper- (and hypo-) methylation of DNA repair genes in cancers
Cancer | Gene | Frequency of promoter hyper-(or hypo-) methylation in cancer |
Colorectal | LIG4 | 82%[78] |
MGMT | 40%-90%[17-21] | |
ERCC1 | 38%[79] | |
WRN | 29%-38%[63,80] | |
MLH1 | 9%-10%[22,81] | |
FEN1 | Frequent (hypo-)[82] | |
MBD4 | Frequent (hyper-)[61] | |
Esophageal | MGMT | 23%-79%[65,83,84] |
MLH1 | 43%[82], 64%[85] | |
MSH2 | 29%[83], 75%[84] | |
Stomach | MGMT | 88%[60] |
MLH1 | 73%[64] | |
WRN | 24%-25%[80,86] | |
FEN1 | Frequent (hypo-)[82] | |
Gastric lymphoma | ATM | 11%[87] |
Table 5 Epigenetic ↑ or ↓ miRNAs, altered in cancers, targeting DNA repair genes
Specific miRNA | DNA repair gene targets | Cancers affected (frequency if measured) | References indicating epigenetic control of miRNA | References indicating target gene(s) of miRNAs | References indicating cancer type(s) affected |
miR-103 miR-107 | RAD51, RAD51D | Osteosarcoma, lung, endometrial, stomach | [100] | [101] | [101] |
miR-34c | UNG | Gastric (70%) field defect gastric (27%) colon (98%) field defect colon (60%) chronic lymphocytic leukemia (18%) small-cell lung cancer (67%) NSCLC (26%) | [102,104] | [103] | [102,105,106] |
miR-31 | PARP1MLH1SMUG1MMS19 | Esophagus (47%) colon | [72] | [21] | [71,107,108] |
miR-124 | KU70 | Colon | [109] | [110] | [109] |
miR-155 | RAD51MLH1MSH2MSH6 | Breast Colon | [90,111] | [23,112] | [23,90] |
let-7a repression increases HMGA2; HMGA2 alters chromatin architecture of and represses ERCC1) | ERCC1 | (Colon) Anaplastic astrocytoma | [90] | [92,113] | [113] |
Let-7b repression increases HMGA1; HMGA1 targets P53 | P53 | Prostate Colon | [90] | [114,115] | [114,115] |
miR-182 | BRCA1NBNRAD17 | Breast Colon | [116] | [117,118] | [107,117,119] |
Table 6 Median mutation frequencies and ranges
Parent/child per generation orcancer type | Mutation frequency per million bases | Mutation frequency per diploid genome |
Parent/child per generation | 0.00000023 | 30-70 |
Colorectal carcinoma | Approximately 5 | Approximately 30000 |
MSS colon cancer | 2.8 | 16800 |
MSI colon cancer (mismatch DNA repair deficient) | 47 | 282000 |
Hepatocellular carcinoma | 4.2 | 25200 |
Esophageal carcinoma (single nucleotide variants) | 2.8 | 16994 |
Range 0.7-9.3 | Range 4516-56528 | |
Esophageal carcinoma (small insertions and deletions) | 994 Range 262-3573 |
- Citation: Bernstein C, Bernstein H. Epigenetic reduction of DNA repair in progression to gastrointestinal cancer. World J Gastrointest Oncol 2015; 7(5): 30-46
- URL: https://www.wjgnet.com/1948-5204/full/v7/i5/30.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v7.i5.30